DAPK3/ZIPK Protein, Human (sf9, GST)

Customer Review

Based on 1 Customer Validation

The DAPK3/ZIPK protein is a multifunctional serine/threonine kinase that complexly regulates apoptosis, autophagy, transcription, translation, and actin cytoskeletal reorganization. Its key roles include coordinating apoptotic and autophagy signaling, influencing smooth muscle contraction, and regulating starvation-induced autophagy. DAPK3/ZIPK Protein, Human (sf9, GST) is the recombinant human-derived DAPK3/ZIPK protein, expressed by Sf9 insect cells , with N-GST labeled tag.

For research use only. We do not sell to patients.
  • Species: Human
  • Source: Sf9 insect cells
  • Storage:
    Stored at -80°C for 1 year from date of receipt. It is stable at -20°C for 3 months after opening. It is recommended to freeze aliquots at -80°C for extended storage. Avoid repeated freeze-thaw cycles.
  • Biological Activity
  • Technical Parameters
  • Product Properties
  • Documentation
  • Help & FAQs

Biological Activity

Description

The DAPK3/ZIPK protein is a multifunctional serine/threonine kinase that complexly regulates apoptosis, autophagy, transcription, translation, and actin cytoskeletal reorganization. Its key roles include coordinating apoptotic and autophagy signaling, influencing smooth muscle contraction, and regulating starvation-induced autophagy. DAPK3/ZIPK Protein, Human (sf9, GST) is the recombinant human-derived DAPK3/ZIPK protein, expressed by Sf9 insect cells , with N-GST labeled tag.

Background

DAPK3/ZIPK, a serine/threonine kinase, intricately regulates diverse cellular processes such as apoptosis, autophagy, transcription, translation, and actin cytoskeleton reorganization. It plays a crucial role in orchestrating both type I apoptotic and type II autophagic cell death signals, depending on the cellular context. DAPK3/ZIPK also governs smooth muscle contraction and is implicated in the regulation of starvation-induced autophagy. Its influence on myosin phosphorylation extends to both smooth muscle and non-muscle cells, where it directly phosphorylates MYL12B and MYL9 or inhibits smooth muscle myosin phosphatase (SMPP1M) via PPP1R12A phosphorylation. In non-muscle cells, it phosphorylates MYL12B, leading to actin cytoskeleton reorganization. Isoform 2, an alternative form of DAPK3/ZIPK, contributes to myosin, PPP1R12A, and MYL12B phosphorylation, inducing the condensation of actin stress fibers into thick bundles. Additionally, DAPK3/ZIPK plays a role in actin filament focal adhesion dynamics, and its function is modulated by RhoD. Moreover, it positively regulates canonical Wnt/beta-catenin signaling, interacts with NLK and TCF7L2, phosphorylates RPL13A upon interferon-gamma activation, enhancing its involvement in transcript-selective translation inhibition. DAPK3/ZIPK's diverse functions also extend to the regulation of cell cycle progression and cell proliferation, potentially acting as a tumor suppressor.

Verified Bioactivity

The kinase activity of this recombinant protein is testing in progress, we cannot offer a guarantee yet.

Technical Parameters

  • Species Human
  • Source Sf9 insect cells
  • Tag N-GST
  • Accession
  • Gene ID
  • Molecular Construction
    • N-term
    • GST
    • DAPK3 (M1-R454)
      Accession # O43293-1
    • C-term
  • Protein Length

    Full Length of Isoform-1

  • Synonyms

    DAPK3; DAP-Like Kinase; Death Associated Protein Kinase 3; DAP Kinase 3; ZIPK; MYPT1 Kinase; ZIP; ZIP-Kinase; Death-Associated Protein Kinase 3; DLK; Zipper-Interacting Protein Kinase; Dlk

  • AA Sequence

    MSTFRQEDVEDHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFENKTDVVLILELVSGGELFDFLAEKESLTEDEATQFLKQILDGVHYLHSKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGETKQETLTNISAVNYDFDEEYFSNTSELAKDFIRRLLVKDPKRRMTIAQSLEHSWIKAIRRRNVRGEDSGRKPERRRLKTTRLKEYTIKSHSSLPPNNSYADFERFSKVLEEAAAAEEGLRELQRSRRLCHEDVEALAAIYEEKEAWYREESDSLGQDLRRLRQELLKTEALKRQAQEEAKGALLGTSGLKRRFSRLENRYEALAKQVASEMRFVQDLVRALEQEKLQGVECGLR

  • Predicted Molecular Mass

    79 kDa

  • Molecular Weight

    Approximately 70 kDa, based on SDS-PAGE under reducing conditions.

  • Purity

    ≥ 85%, as determined by reducing SDS-PAGE.

Product Properties

Appearance

Solution.

Formulation

Supplied as a 0.22 μm filtered solution of 20 mM Tris, 500 mM NaCl, 10 mM GSH, pH 7.4
Note: For SPR assay, please replace the buffer. Primary amine components (e.g., Tris, imidazole) can affect protein-coupled chips.

Endotoxin Level

<1 EU/μg, determined by LAL method.

Reconstitution

Please use rapid thawing with running water to thaw the protein.

Storage & Stability

Stored at -80°C for 1 year from date of receipt. It is stable at -20°C for 3 months after opening. It is recommended to freeze aliquots at -80°C for extended storage. Avoid repeated freeze-thaw cycles.

Shipping

Shipping with dry ice.

Calculators

Reconstitution Calculator

Volume (to add to vial) = Mass (in vial) ÷ Desired Reconstitution Concentration

Volume (to add to vial) Volume (to add to vial)
=
Mass (in vial) Mass (in vial)
÷
Desired Reconstitution Concentration Desired Reconstitution Concentration
Dilution Calculator

Concentration (start) × Volume (start) = Concentration (final) × Volume (final)

Concentration (start) Concentration (start)
×
Volume (start) Volume (start)
=
Concentration (final) Concentration (final)
×
Volume (final) Volume (final)
The Specific Activity Calculator Equation
  • Specific Activity (Unit/mg)
  • Biological Activity (ED50)

Specific Activity (Unit/mg) = 106 ÷ Biological Activity (ED50)

Specific Activity (Unit/mg) Specific Activity (Unit/mg)
Unit/mg
= 106 ÷
Biological Activity (ED50) Biological Activity (ED50)
106 ÷
ng/mL
MOQ
Minimum order quantity
100 mg

Get Quote In-stock

Other size
Get Quote
Please select quantity
Amount: USD 0.00